Senior Manager, Global Scientific Communications & Engagement Strategy Global Publication Lead
Amgen
Summary
The Senior Manager, Scientific Communications & Engagement Disease Global Publication Lead, is accountable for developing and executing comprehensive, high-impact scientific publication, communication and customer engagement strategies in alignment with product and therapeutic area objectives. This role collaborates across Medical Affairs, and Clinical Development, to ensure consistent, compliant, and compelling communication of scientific and clinical evidence.
Job description
Key Responsibilities
Strategic Planning and Oversight
- Lead development and oversee implementation of global and US scientific communication and HCP engagement plans, in close partnership with product medical leads and field leaders
- Adapt strategies based on disease landscape evolution, emerging data, channel innovation, and cross-functional insights
- Partner with Medical Data & Analytics, product medical leads, and field leaders to define, implement, and track metrics to assess impact of publications and enhanced content.
- Partner with Amgen India to translate the scientific communication and HCP engagement plan into global and US content (publications, Global and US medical & scientific content, US payer content)
Publications and Scientific Exchange
- Develop the product publication plan and manage the publication planning and execution process
- Develop the strategic scientific content brief, to ensure alignment of publications with the scientific narrative and guide development of publication deliverables (manuscripts, abstracts, posters, oral presentations, enhanced content) by Amgen India
- Maintain adherence to ICMJE and Good Publication Practice (GPP) guidelines
Operational Excellence and Innovation
- Provide input to and adopt ongoing process improvements and standardization, systems enhancements, and digital innovation
- Define and track key performance indicators (KPIs) to measure impact and efficiency.
- Assist in training of Amgen Scientific Communications staff in India and across geographies, as relevant
Leadership and Collaboration
- Cultivate collaboration across Amgen India Scientific Communications and cross-functional partners and affiliates
- Manage external vendors and agencies to ensure quality and compliance, and where required assist in transition of vendor activities to Amgen India
- Provide mentorship, as needed
Requirements
- Doctorate degree and 2 years of Medical/Scientific Affairs experience OR Master’s degree and 6 years of Medical/Scientific Affairs experience OR Bachelor’s degree and 8 years of Medical/Scientific Affairs experience OR Associate’s degree and 10 years of Medical/Scientific Affairs experience OR High school diploma / GED and 12 years of Medical/Scientific Affairs experience
- Advanced scientific degree (MD, PharmD, PhD, DO) with 4+ years in Medical/Scientific Affairs, Clinical Development, or related field
- Proven experience in publication strategy, publication development, and vendor management in the biopharmaceutical industry, and/or clinical or research in the therapeutic area
- Experience in publication planning, publications guidelines and transparency standards (e.g., ICMJE, current Good Publication Practice (GPP) Guidelines GPP)
- Strong analytical and communication skills
- Experience in multi-channel scientific platforms and digital engagement capabilities at a pharma company or at a digital agency primarily or exclusively serving pharma companies
- Artificial Intelligence literacy and digital fluency
- Travel required (approximately 10–20%)
Benefits
- Health insurance
- Dental coverage
- Vision coverage
- Life insurance
- Disability insurance
- Retirement and savings plan
- Flexible spending accounts
- Annual bonus program
- Stock-based long-term incentives
- Paid time off
Company overview
Amgen Inc. is a leading American multinational biopharmaceutical company headquartered in Thousand Oaks, California, founded in 1980. As one of the world's largest independent biotechnology companies, Amgen specializes in discovering, developing, manufacturing, and delivering innovative human therapeutics. The company focuses on six key therapeutic areas: inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience. Amgen's portfolio includes blockbuster drugs such as Enbrel for autoimmune diseases, Prolia and XGEVA for osteoporosis, Repatha for cholesterol management, Otezla for psoriasis, and Neulasta for chemotherapy-induced neutropenia. With approximately 28,000 employees worldwide, Amgen operates as a component of both the Dow Jones Industrial Average and Nasdaq-100 indices. The company maintains a robust research and development pipeline with numerous clinical programs across various stages, leveraging cutting-edge biotechnology and human genetic data to address some of the world's most challenging diseases. Amgen's manufacturing capabilities span multiple global locations, and it distributes products through pharmaceutical wholesale distributors and direct-to-consumer channels.